Ipamorelin

<h2>Ipamorelin – Selective GHRP for Research Applications</h2><p><strong>Ipamorelin</strong> is a synthetic <strong>Growth Hormone–Releasing Peptide (GHRP)</strong><br>used in laboratory research to study the <strong>stimulation of growth hormone (GH) release</strong><br>via the <em>ghrelin receptor (GHSR)</em>. This peptide is known for its selective and controlled<br>activity on the <strong>hypothalamic–pituitary axis</strong> in research models.</p><p>Within in-vitro studies, Ipamorelin is of interest due to its targeted interaction with<br>ghrelin receptors, without significant involvement in cortisol- or prolactin-related pathways<br>that are observed with some other GHRPs. Ipamorelin is manufactured according to strict<br>quality standards and verified using<br><em>High-Performance Liquid Chromatography (HPLC)</em> to ensure a purity of<br><strong>≥ 99%</strong>.</p><h3>Key specifications</h3><p>SpecificationValue / descriptionNameIpamorelinMolecular formulaC38H49N9O5Molecular weight≈ 711.86 DaFormLyophilized powderPurity≥ 99% (HPLC tested)Storage conditionsStore refrigerated, protected from light and moisture</p><h3>Application &amp; use (research only)</h3><ul><li><p>Intended exclusively for <strong>in-vitro research purposes</strong>.</p></li><li><p>Not suitable for human or veterinary consumption or medical use.</p></li><li><p>Applicable to endocrinological and biochemical research on growth hormone release and ghrelin receptor activity.</p></li><li><p>Lyophilized form supports stable storage and controlled laboratory handling.</p></li></ul><p></p>